t
IP Group plc announced on 15 April 2026 the publication of its Annual Report and Accounts for the year ended 31 December 2025. An electronic copy is available on the company website, and a copy will be available for inspection at www.fca.org.uk. The Company's Annual General Meeting is scheduled for 18 June 2026 at 11:00 am.
| Date | 15 Apr 2026 |
| Time | 17:00:00 |
| Category | Results |
| ID | 4761A |
|
FOR RELEASE ON |
15 April 2026 |
IP Group - 2025 Annual Report
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it has published its Annual Report and Accounts for the year ended 31 December 2025.
In compliance with Listing Rule 9.6.3, a copy of the Annual Report and Accounts for the year ended 31 December 2025 ("2025 ARA") will shortly be available for inspection at www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.
An electronic copy of the 2025 ARA is available on the Investor Relations section of the IP Group website at www.ipgroupplc.com/investor-relations. Printed copies of the 2025 ARA are being posted to shareholders who have requested hard copies.
The Company's Annual General Meeting ("AGM") is scheduled to be held at 11.00 am on 18 June 2026 at the offices of the Company at 3 Pancras Square, King's Cross, London, N1C 4AG, with refreshments available from 10.30 am. The Notice of Meeting for the AGM together with the related proxy form and voting instructions will be published separately in the coming weeks.
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Alex Donaldson |
+44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS